The Hormone Center

The Hormone Center in Carnegie, Pennsylvania operates under the medical direction of Lauren Loya, M.D., providing hormone optimization and metabolic medicine to patients throughout the Pittsburgh metropolitan area. Dr. Loya's practice addresses thyroid dysfunction, adrenal imbalances, and age-related hormone decline through laboratory-guided treatment protocols that combine bioidentical hormone replacement therapy with peptide-based interventions. The clinic serves Pennsylvania residents through both in-person appointments at the Carnegie location and telehealth consultations for established patients across the state.

The practice incorporates GLP-1 receptor agonist peptides—specifically liraglutide and semaglutide—into comprehensive metabolic treatment plans for patients with weight management challenges, insulin resistance, and metabolic syndrome. These peptides function by mimicking incretin hormones that regulate blood sugar and appetite signaling. Dr. Loya prescribes these medications as part of structured programs that include metabolic panel monitoring, body composition tracking, and nutritional guidance rather than as standalone weight loss solutions. Patients receiving GLP-1 therapy undergo baseline cardiovascular and thyroid function assessment, as these peptides can affect heart rate and may interact with existing thyroid conditions.

Dr. Loya's approach to thyroid treatment extends beyond standard TSH testing to include comprehensive thyroid panels measuring free T3, free T4, reverse T3, and thyroid antibodies. The clinic utilizes saliva testing for cortisol rhythm assessment when evaluating adrenal function, providing four-point diurnal cortisol mapping that reveals patterns standard blood tests cannot capture. For bioidentical hormone replacement, the practice prescribes estradiol, progesterone, testosterone, and DHEA in physiologic doses tailored to individual hormone panels and symptom profiles. Treatment protocols are adjusted based on follow-up laboratory results typically obtained at three-month intervals during the initial optimization phase.

Patients beginning care at The Hormone Center complete intake questionnaires detailing symptom history, previous treatments, and current supplement regimens before their initial consultation with Dr. Loya. The first appointment includes discussion of laboratory findings, physical examination when conducted in person, and development of a treatment plan with defined monitoring intervals. The clinic provides injection training for patients prescribed self-administered therapies and maintains communication channels for questions that arise during treatment. Follow-up visits assess symptom response, review updated laboratory values, and modify treatment protocols based on clinical progress and patient-reported outcomes.

The Carnegie office location provides access to patients throughout Allegheny County and surrounding western Pennsylvania communities, while the telehealth option accommodates established patients who prefer remote follow-up appointments or face distance barriers to in-person care. The hybrid consultation model allows Dr. Loya to maintain continuity of care for patients whose work schedules or geographic locations make regular office visits impractical. Pennsylvania residents interested in hormone optimization or metabolic peptide therapy can initiate care through the clinic's patient intake process, which determines whether initial evaluation requires in-person assessment or can be conducted via telehealth based on individual clinical circumstances and treatment goals.